Pain-care consolidation has a peculiar way of looking tidy in a release and messy in the real world. Resolve Pain Solutions announced on November 18, 2026, that it has acquired Cahaba Pain and Spine Care, an established provider serving greater Birmingham, Alabama. On its face, this is a straightforward expansion move: buy a respected local practice, retain its physician leadership, add shared support, and widen the platform’s reach in a market Resolve already knows.
The Physicians Are the Actual Asset
The important detail is not some flashy new logo. It is that Cahaba’s named physician leaders—Dr. R. Brian Thoma, Dr. T. Wade Martin, Dr. Taylor Scruggs, and Dr. Sterling Anderson—have joined Resolve as partners, alongside the practice’s other providers and staff. In physician practice deals, continuity is the whole ballgame. Buildings, billing systems, and back-office playbooks can be changed. Trusted clinicians with local referral relationships cannot be swapped out like office furniture without consequences.
Resolve appears to understand that point. Cahaba will continue operating independently from Resolve’s existing metro Birmingham practice, Alabama Anesthesiology & Pain Consultants, while receiving shared resources and strategic support. That is a more sensible posture than cramming two local practices together overnight and calling the disruption “synergy.” Patients dealing with chronic pain do not need a corporate integration experiment layered onto their care.
A Birmingham Cluster Takes Shape
From an investor’s seat, this looks like a geographic-density play rather than a random land grab. Resolve is building in the Southeast, and Birmingham now has two distinct practices inside its orbit. Keeping Cahaba independent while preserving its local identity may help Resolve hold onto physician engagement and patient familiarity, while still gaining scale behind the scenes. That can include administrative support, growth planning, recruiting capacity, and whatever operational infrastructure the platform can credibly provide.
There is also a governance breadcrumb worth noting: Dr. T. Wade Martin will join Resolve’s Physician Advisory Board. That does not magically guarantee a smooth marriage, of course. But bringing acquired physicians into the decision-making apparatus is usually a healthier signal than treating them as mere employees after the papers are signed. In healthcare services, the people delivering care have a nasty habit of leaving when they feel ignored. Shocking, I know.
- Resolve gains another established foothold in a core Southeast market.
- Cahaba retains its operating identity rather than being immediately folded into a neighboring practice.
- The deal brings physician leaders into the partnership structure and advisory process.
- Management says its broader plan includes acquisitions, core-market expansion, and de novo locations.
The Missing Numbers Matter More Than the Cheerleading
Still, nobody should pretend this announcement provides enough information to judge the economics. Resolve did not disclose a purchase price, Cahaba’s revenue, patient volume, clinic count, profitability, payer mix, debt assumptions, or expected integration costs. Those are not trivial blanks; they are the numbers that separate a disciplined platform build from an expensive collection of medical practices.
Resolve describes itself as a high-growth comprehensive pain-management platform and a portfolio company of Compass Group Equity Partners. That backing gives the strategy an obvious financial context: acquire strong practices, deepen existing markets, support expansion, and potentially create a broader network with greater operating leverage. Fine. Plenty of sponsor-backed healthcare platforms have pursued that script. The hard part is not writing it down. The hard part is maintaining clinical quality, physician retention, compliance discipline, and patient access while growth targets keep knocking at the door.
Execution Will Decide Whether This Sticks
The most encouraging feature here is the stated effort to build on Cahaba’s existing strengths instead of pretending scale alone cures every business problem. Comprehensive pain management is a sensitive corner of healthcare, where patient experience and clinical judgment deserve more respect than a spreadsheet usually gives them. Resolve’s claims around supporting teams and expanding access are reasonable ambitions, but they remain ambitions until the integration proves them out.
For sector watchers, this is a credible strategic add-on, not a deal to celebrate blindly. Birmingham density, retained physician leadership, and an independent operating model all make practical sense. What remains fuzzy is the financial lift and the operational burden. Resolve has added a meaningful local partner; whether it has added durable value will depend on the unglamorous work after the announcement fades.